Silicon Laboratories Inc. — Form 10-Q Summary
Period clarification: The request metadata says 2011 Q1, but the filing covers the quarter ended March 31, 2012 (fiscal 2012 Q1), compared with the quarter ended April 2, 2011. Financial statements are unaudited. Unless otherwise noted, amounts below are in U.S. dollars.
Business context and reporting period
Silicon Laboratories designs and develops analog-intensive, mixed-signal integrated circuits for communications, consumer, industrial, automotive, medical, and power-management applications. It operates as a fabless semiconductor company, relying on third parties for wafer fabrication, assembly, and testing. Sales are primarily IC products. Revenue outside the United States was 87% of the quarter’s total.
Financial performance and liquidity
| Metric | Q1 2012 | Comparable 2011 period |
|---|---|---|
| Revenue | $125.7 million | $119.6 million |
| Gross margin | $75.1 million; 59.7% | $72.2 million; 60.3% |
| Operating expenses | $58.3 million | $67.2 million |
| Operating income | $16.8 million; 13.3% of revenue | $4.9 million; 4.1% of revenue |
| Net income (loss) | $14.3 million | $(2.0) million |
| Diluted EPS | $0.33 | $(0.04) |
| Cash from operating activities | $26.1 million | $(2.6) million |
Revenue increased 5.1% year over year. Product unit volume rose 14.9%, while average selling prices fell 8.5%. Gross margin percentage declined 0.6 percentage points. R&D was $32.9 million, or 26.2% of revenue; SG&A was $25.4 million, or 20.2%.
At March 31, 2012, cash and cash equivalents were $98.0 million, short-term investments $235.3 million, and long-term investments $17.7 million. Management reported $333.3 million in cash, cash equivalents, and short-term investments, including approximately $178.1 million held by U.S. entities. Current assets were $481.5 million and current liabilities $90.3 million. Total liabilities were $109.4 million and stockholders’ equity $623.4 million. The filing does not provide a clear separate borrowing or debt balance.
Cash increased $3.1 million to $98.0 million. Investing activities used $25.6 million, principally reflecting investment purchases; financing activities provided $2.5 million. Accounts receivable rose to $61.4 million; DSO was 44 days versus 39 at year-end. Inventory was $34.3 million; DOI was 61 days versus 63.
Material changes versus the prior comparable period
- Operating income improved to $16.8 million from $4.9 million, and the company moved from a net loss to net income.
- Lower operating expenses—especially SG&A, down 20.3%—supported operating profit growth. The prior-year period included acquisition-related costs for Spectra Linear; the current period also benefited from a decline in acquisition-related contingent consideration.
- Gross margin dollars increased 4.1%, but gross margin percentage eased from 60.3% to 59.7%, partly due to product mix.
- Operating cash flow improved from an outflow of $2.6 million to an inflow of $26.1 million. The prior-year period included a $27.5 million net cash acquisition payment and $7.2 million of debt payments.
- The effective tax rate was 16.3% versus 134.3%. The prior period included a tax charge related to an intercompany technology license and acquisition-related nondeductible costs; the current period also included a one-time increase in deductibility of stock compensation associated with the CEO’s separation.
Guidance, commentary, risks, and unusual items
- Q2 outlook: Management expected revenue to increase 3% to 7% sequentially and diluted EPS of $0.24 to $0.29. It expected R&D to increase modestly in absolute dollars; SG&A was expected to remain relatively stable excluding expected CEO-separation charges.
- CEO transition: Former CEO Necip Sayiner agreed to serve through April 18, 2012 and as a non-executive advisor through July 19, 2012. The separation agreement is expected to result in approximately $3.2 million of expense recognized over the service period. It includes cash and benefits, accelerated vesting of certain awards, and an extended option exercise period.
- Investments: The company held $19.2 million par value of auction-rate securities with failed auctions, valued at $17.7 million. Their principal may remain inaccessible until a successful auction, redemption, third-party sale, or maturity (contractual maturities range from 2029 to 2046). Management did not expect to need the funds before maturity and recorded no other-than-temporary impairment.
- Capital allocation: No shares were repurchased in Q1. In April 2012, after quarter-end, the Board authorized a new program to repurchase up to $100 million of stock through January 2013. Fiscal 2012 capital expenditures were estimated at $8 million to $12 million.
- Key risks: Revenue and margins face pressure from declining selling prices, product and semiconductor-industry cycles, customer concentration, long design and qualification cycles, and reliance on third-party manufacturing and testing capacity. Samsung represented more than 10% of revenue; two distributors, Edom Technology and Avnet, also each represented more than 10%. The ten largest customers accounted for 46% of revenue. Management noted that customer orders may change or be cancelled with little notice and that significant sales cycles can delay revenue realization.
- Contingencies and controls: The company reported ordinary-course legal proceedings and did not expect them to materially adversely affect financial position or results. It had $11.3 million of gross unrecognized tax benefits and believed approximately $3.5 million could decrease within 12 months due to a statute-of-limitations lapse. Disclosure controls were assessed as effective, with no materially affecting change in internal controls reported.
- Management stated that existing cash and investment balances should meet capital needs for at least 12 months. Forward-looking statements remain subject to risks and are not guarantees of future results.
Important facts for investors to verify
- Confirm the reporting-period mismatch: the filing itself is for Q1 2012, not Q1 2011.
- Track whether unit growth can continue to offset falling average selling prices, and whether gross-margin percentage stabilizes.
- Assess customer and channel concentration, including the exposure to Samsung, Edom Technology, and Avnet.
- Monitor execution against Q2 revenue and EPS guidance and the expected CEO-transition expense.
- Review liquidity quality: failed-auction securities are long-dated and not readily accessible, despite the company’s stated liquidity position.
- Check subsequent share repurchases under the April 2012 authorization and the use of cash for acquisitions or other investment.